XTalks

DECEMBER 4, 2024

Jupiter Neurosciences, a clinical-stage pharma company specializing in neuroinflammation, made its public market debut with an initial public offering (IPO) on the Nasdaq Capital Market under the symbol “JUNS.” ” The company priced 2,750,000 shares of common stock at $4.00

Bioavailability 111

Bioavailability Genetic Disease Marketing RNA 111

pharmaphorum

MARCH 16, 2021

Holland told a virtual conference on AI in February that the company distils scientific knowledge about antibodies along with the results of hundreds of thousands of experiments to develop models that can predict how antibodies bind to their antigen targets, and spot molecules that may be missed with current approaches.

Antibody 101

Antibody Bioavailability Engineer Drugs 101

pharmaphorum

JANUARY 29, 2021

While tanezumab is an antibody and has to be delivered by subcutaneous injection, AK1780 is orally bioavailable. The new drug has already cleared phase 1 single and multiple ascending dose and clinical pharmacology studies, according to Lilly.

Licensing 52

Licensing Licensing Bioavailability Antibody 52

Pharmaceutical Technology

JUNE 14, 2023

This, coupled with small pharma companies being unable to acquire or access containment capabilities in-house, means that the demand for innovative specialized small molecule capabilities remains high. Furthermore, the number of marketed high potency APIs (HPAPIs) tends to increase over time as more HPAPIs in development gain approval.

Containment 130

Containment Manufacturing Contract Manufacturing Bioavailability 130

The Pharma Data

MAY 16, 2021

and could change how “bioavailable” the all-important EBM triggering nutrients are. Bioavailable is a word that scientists use to describe how easy it is for your body to use a nutrient…. I know I’m not going to reach as many men as the Big Pharma companies with 100 Million Dollar advertising budgets….

Production 52

Production Containment Research Doctor 52